San Diego, CA -- (SBWIRE) -- 05/02/2016 -- The acquisition of St. Jude Medical, Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NYSE:STJ shares, concerning whether the takeover of St. Jude Medical, Inc. by Abbott is unfair to NYSE:STJ stockholders.

Investors who purchased shares of St. Jude Medical, Inc. (NYSE:STJ) and currently hold any of those NYSE:STJ shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain officers and directors of St. Jude Medical, Inc breached their fiduciary duties owed to NYSE:STJ investors in connection with the proposed acquisition.

On April 28, 2016, Abbott and St. Jude Medical, Inc. (NYSE:STJ) announced an agreement for Abbott to acquire St. Jude Medical, Inc. Under the agreement, St. Jude Medical, Inc. shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately $85 per share.

However, the investigation concerns whether the offer is unfair to NYSE:STJ stockholders. More specifically, the investigation concerns whether the St. Jude Medical Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

On April 28, 2016, NYSE:STJ shares closed at $77.78 per share.

Those who are current investors in St. Jude Medical, Inc. shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com